Literature DB >> 20211489

Rapid and durable molecular response of refractory T-cell large granular lymphocyte leukemia after alemtuzumab treatment.

Hélène Monjanel, Christophe Hourioux, Flavie Arbion, Philippe Colombat, Séverine Lissandre, Marie Paule Regner, Delphine Senecal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20211489     DOI： 10.1016/j.leukres.2010.01.019

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  3 in total

Review 1.  The pathogenesis and treatment of large granular lymphocyte leukemia.

Authors:  Steven Nathaniel Steinway; Francis LeBlanc; Thomas P Loughran
Journal:  Blood Rev       Date:  2014-03-07       Impact factor: 8.250

2.  How I treat LGL leukemia.

Authors:  Thierry Lamy; Thomas P Loughran
Journal:  Blood       Date:  2010-12-29       Impact factor: 22.113

3.  Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study.

Authors:  Bogdan Dumitriu; Sawa Ito; Xingmin Feng; Nicole Stephens; Muharrem Yunce; Sachiko Kajigaya; Joseph J Melenhorst; Olga Rios; Priscila Scheinberg; Fariba Chinian; Keyvan Keyvanfar; Minoo Battiwalla; Colin O Wu; Irina Maric; Liqiang Xi; Mark Raffeld; Pawel Muranski; Danielle M Townsley; Neal S Young; Austin J Barrett; Phillip Scheinberg
Journal:  Lancet Haematol       Date:  2015-12-17       Impact factor: 18.959
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.